Amur Minerals Corporation acquires Extruded Pharmaceuticals

LONDON: Amur Minerals Corporation, now an AIM Rule 15 cash shell, has executed a sale and purchase agreement to acquire Extruded Pharmaceuticals Limited (EPL), a UK-based innovator in cancer treatment technology. The acquisition, valued at £5.5 million, will be satisfied through the issuance of 23,939,986 new ordinary shares. This strategic acquisition is a reverse takeover…

Amur Minerals sells Carlo Holdings for $6.137 million

LONDON, UK: Amur Minerals Corporation, a nickel-copper sulphide mineral exploration and resource development company which possesses a wholly owned nickel sulphide asset located in the far east of Russia, announced the sale of its wholly-owned subsidiary Carlo Holdings Limited (CHL) for a cash consideration of US$6.137 million pursuant to a share sale agreement entered into…